GB0203391D0 - Compounds for imaging alzheimer's disease - Google Patents

Compounds for imaging alzheimer's disease

Info

Publication number
GB0203391D0
GB0203391D0 GB0203391A GB0203391A GB0203391D0 GB 0203391 D0 GB0203391 D0 GB 0203391D0 GB 0203391 A GB0203391 A GB 0203391A GB 0203391 A GB0203391 A GB 0203391A GB 0203391 D0 GB0203391 D0 GB 0203391D0
Authority
GB
United Kingdom
Prior art keywords
disease
compounds
imaging alzheimer
alzheimer
imaging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0203391A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Hammersmith Imanet Ltd
Original Assignee
Amersham PLC
Imaging Research Solutions Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham PLC, Imaging Research Solutions Ltd filed Critical Amersham PLC
Priority to GB0203391A priority Critical patent/GB0203391D0/en
Publication of GB0203391D0 publication Critical patent/GB0203391D0/en
Priority to US10/504,231 priority patent/US20050123477A1/en
Priority to JP2003567449A priority patent/JP2005523903A/en
Priority to PCT/GB2003/000584 priority patent/WO2003068269A1/en
Priority to AU2003212490A priority patent/AU2003212490A1/en
Priority to EP03708309A priority patent/EP1474178A1/en
Priority to CA002474411A priority patent/CA2474411A1/en
Ceased legal-status Critical Current

Links

GB0203391A 2002-02-13 2002-02-13 Compounds for imaging alzheimer's disease Ceased GB0203391D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GB0203391A GB0203391D0 (en) 2002-02-13 2002-02-13 Compounds for imaging alzheimer's disease
US10/504,231 US20050123477A1 (en) 2002-02-13 2003-02-12 Benzothiazole derivatives for in vivo imaging of amloid plaques
JP2003567449A JP2005523903A (en) 2002-02-13 2003-02-12 Benzothiazole derivatives for in vivo imaging of amyloid plaques
PCT/GB2003/000584 WO2003068269A1 (en) 2002-02-13 2003-02-12 Benzothiazole derivatives for in vivo imaging of amyloid plaques
AU2003212490A AU2003212490A1 (en) 2002-02-13 2003-02-12 Benzothiazole derivatives for in vivo imaging of amyloid plaques
EP03708309A EP1474178A1 (en) 2002-02-13 2003-02-12 Benzothiazole derivatives for in vivo imaging of amyloid plaques
CA002474411A CA2474411A1 (en) 2002-02-13 2003-02-12 Benzothiazole derivatives for in vivo imaging of amyloid plaques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0203391A GB0203391D0 (en) 2002-02-13 2002-02-13 Compounds for imaging alzheimer's disease

Publications (1)

Publication Number Publication Date
GB0203391D0 true GB0203391D0 (en) 2002-03-27

Family

ID=9930982

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0203391A Ceased GB0203391D0 (en) 2002-02-13 2002-02-13 Compounds for imaging alzheimer's disease

Country Status (1)

Country Link
GB (1) GB0203391D0 (en)

Similar Documents

Publication Publication Date Title
EP1809601A4 (en) Compounds for alzheimer's disease
IL160884A0 (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
EE200200716A (en) Compounds for the Treatment of Alzheimer's Disease
AU1403402A (en) Radiopharmaceuticals for diagnosing alzheimer's disease
AU2003206413A8 (en) Substituted amino carboxamides for the treatment of alzheimer's disease
AU2610901A (en) Predictive diagnostic for alzheimer's disease
GB2384155B (en) Patient positioning by video imaging
IL175667A0 (en) Novel imaging agents
ITMI20010985A0 (en) DRUGS FOR ALZHEIMER'S DISEASE
AU2002315131A1 (en) Aminediols as agents for the treatment of alzheimer's disease
AU2001236592A1 (en) Methods for diagnosis of alzheimer's disease
ZA200603178B (en) Quick test for the diagnosis of Alzheimer's disease
AU2003303141A8 (en) Hydroxypropyl amides for the treatment of alzheimer's disease
GB0228490D0 (en) Novel imaging compounds
AU2003273310A1 (en) Substituted aminoethers for the treatment of alzheimer's disease
EP1181550A4 (en) Methods for the identification of compounds for the treatment of alzheimer's disease
AU2003251962A8 (en) Screening for alzheimer's disease
GB0302465D0 (en) "13C-labelled synthesis"
AU2003299101A1 (en) Compounds for the treatment of alzheimer's disease
GB0223249D0 (en) Improved imaging agents
AU2003236714A8 (en) Diagnosis of alzheimer's disease based on the habeta42:habeta40 ratio
GB0217713D0 (en) Compounds for imaging alzheimer's disease
GB0203391D0 (en) Compounds for imaging alzheimer's disease
EP1832877A4 (en) Method of examining alzheimer's disease
GB0127473D0 (en) Compounds for imaging alzheimer's disease

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)